The Accuracy of Survival Time Prediction for Patients with Glioma Is Improved by Measuring Mitotic Spindle Checkpoint Gene Expression

被引:54
作者
Bie, Li [1 ,2 ]
Zhao, Gang [1 ]
Cheng, Pui [3 ]
Rondeau, Gaelle [3 ]
Porwollik, Steffen [3 ]
Ju, Yan [1 ]
Xia, Xiao-Qin [2 ,3 ,4 ]
McClelland, Michael [2 ,3 ]
机构
[1] Jilin Univ, Clin Hosp 1, Dept Neurosurg, Changchun 130023, Peoples R China
[2] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA
[3] Vaccine Res Inst San Diego, San Diego, CA USA
[4] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China
来源
PLOS ONE | 2011年 / 6卷 / 10期
关键词
CHROMOSOMAL INSTABILITY; CELL-PROLIFERATION; CANCER-CELLS; ANEUPLOIDY; BUBR1; ASTROCYTOMAS; TUMORS; GRADE; CLASSIFICATION; GLIOBLASTOMA;
D O I
10.1371/journal.pone.0025631
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Identification of gene expression changes that improve prediction of survival time across all glioma grades would be clinically useful. Four Affymetrix GeneChip datasets from the literature, containing data from 771 glioma samples representing all WHO grades and eight normal brain samples, were used in an ANOVA model to screen for transcript changes that correlated with grade. Observations were confirmed and extended using qPCR assays on RNA derived from 38 additional glioma samples and eight normal samples for which survival data were available. RNA levels of eight major mitotic spindle assembly checkpoint (SAC) genes (BUB1, BUB1B, BUB3, CENPE, MAD1L1, MAD2L1, CDC20, TTK) significantly correlated with glioma grade and six also significantly correlated with survival time. In particular, the level of BUB1B expression was highly correlated with survival time (p<0.0001), and significantly outperformed all other measured parameters, including two standards; WHO grade and MIB-1 (Ki-67) labeling index. Measurement of the expression levels of a small set of SAC genes may complement histological grade and other clinical parameters for predicting survival time.
引用
收藏
页数:10
相关论文
共 74 条
[1]   High expression of BUBR1 is one of the factors for inducing DNA aneuploidy and progression in gastric cancer [J].
Ando, Koji ;
Kakeji, Yosihiro ;
Kitao, Hiroyuki ;
Iimori, Makoto ;
Zhao, Yan ;
Yoshida, Rintaro ;
Oki, Eiji ;
Yoshinaga, Keiji ;
Matumoto, Takuya ;
Morita, Masaru ;
Sakaguchi, Yoshihisa ;
Maehara, Yoshihiko .
CANCER SCIENCE, 2010, 101 (03) :639-645
[2]   The spindle checkpoint, aneuploidy, and cancer [J].
Bharadwaj, R ;
Yu, HT .
ONCOGENE, 2004, 23 (11) :2016-2027
[3]   A Network Model of a Cooperative Genetic Landscape in Brain Tumors [J].
Bredel, Markus ;
Scholtens, Denise M. ;
Harsh, Griffith R. ;
Bredel, Claudia ;
Chandler, James P. ;
Renfrow, Jaclyn J. ;
Yadav, Ajay K. ;
Vogel, Hannes ;
Scheck, Adrienne C. ;
Tibshirani, Robert ;
Sikic, Branimir I. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (03) :261-275
[4]   Reduced level of the spindle checkpoint protein BUB1B is associated with aneuploidy in colorectal cancers [J].
Burum-Auensen, E. ;
DeAngelis, P. M. ;
Schjolberg, A. R. ;
Roislien, J. ;
Mjaland, O. ;
Clausen, O. P. F. .
CELL PROLIFERATION, 2008, 41 (04) :645-659
[5]   Kinetochore structure and function [J].
Chan, GK ;
Liu, ST ;
Yen, TJ .
TRENDS IN CELL BIOLOGY, 2005, 15 (11) :589-598
[6]   Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System Clinical article [J].
Chang, Edward F. ;
Clark, Aaron ;
Jensen, Randy L. ;
Bernstein, Mark ;
Guha, Abhijit ;
Carrabba, Giorgio ;
Mukhopadhyay, Debabrata ;
Kim, Won ;
Liau, Linda M. ;
Chang, Susan M. ;
Smith, Justin S. ;
Berger, Mitchel S. ;
McDermott, Michael W. .
JOURNAL OF NEUROSURGERY, 2009, 111 (02) :203-210
[7]   Comprehensive genomic characterization defines human glioblastoma genes and core pathways [J].
Chin, L. ;
Meyerson, M. ;
Aldape, K. ;
Bigner, D. ;
Mikkelsen, T. ;
VandenBerg, S. ;
Kahn, A. ;
Penny, R. ;
Ferguson, M. L. ;
Gerhard, D. S. ;
Getz, G. ;
Brennan, C. ;
Taylor, B. S. ;
Winckler, W. ;
Park, P. ;
Ladanyi, M. ;
Hoadley, K. A. ;
Verhaak, R. G. W. ;
Hayes, D. N. ;
Spellman, Paul T. ;
Absher, D. ;
Weir, B. A. ;
Ding, L. ;
Wheeler, D. ;
Lawrence, M. S. ;
Cibulskis, K. ;
Mardis, E. ;
Zhang, Jinghui ;
Wilson, R. K. ;
Donehower, L. ;
Wheeler, D. A. ;
Purdom, E. ;
Wallis, J. ;
Laird, P. W. ;
Herman, J. G. ;
Schuebel, K. E. ;
Weisenberger, D. J. ;
Baylin, S. B. ;
Schultz, N. ;
Yao, Jun ;
Wiedemeyer, R. ;
Weinstein, J. ;
Sander, C. ;
Gibbs, R. A. ;
Gray, J. ;
Kucherlapati, R. ;
Lander, E. S. ;
Myers, R. M. ;
Perou, C. M. ;
McLendon, Roger .
NATURE, 2008, 455 (7216) :1061-1068
[8]   Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas - Data from the SEER program, 1973-2001 [J].
Claus, EB ;
Black, PM .
CANCER, 2006, 106 (06) :1358-1363
[9]   A multigene predictor of outcome in glioblastoma [J].
Colman, Howard ;
Zhang, Li ;
Sulman, Erik P. ;
McDonald, J. Matthew ;
Shooshtari, Nasrin Latif ;
Rivera, Andreana ;
Popoff, Sonya ;
Nutt, Catherine L. ;
Louis, David N. ;
Cairncross, J. Gregory ;
Gilbert, Mark R. ;
Phillips, Heidi S. ;
Mehta, Minesh P. ;
Chakravarti, Arnab ;
Pelloski, Christopher E. ;
Bhat, Krishna ;
Feuerstein, Burt G. ;
Jenkins, Robert B. ;
Aldape, Ken .
NEURO-ONCOLOGY, 2010, 12 (01) :49-57
[10]   Gene Expression Profiling Reveals a New Classification of Adrenocortical Tumors and Identifies Molecular Predictors of Malignancy and Survival [J].
de Reynies, Aurelien ;
Assie, Guillaume ;
Rickman, David S. ;
Tissier, Frederique ;
Groussin, Lionel ;
Rene-Corrail, Fernande ;
Dousset, Bertrand ;
Bertagna, Xavier ;
Clauser, Eric ;
Bertherat, Jerome .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (07) :1108-1115